Director, Pulmonary Hypertension and Right Heart Failure Program, Temple University Hospital
Cardiology
Dr. Paul Forfia, MD
|
|
Give Review
Paul Forfia practices Cardiology. He attended New York Medical College. He has 2 awards "Philadelphia Magazine" and "CMS Meaningful Use Stage 1 Certification". Paul Forfia is a published physician. He published 42 publications, including: 'Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney.' Dr. Paul Forfia accepts Medicare.
Publications
- Four-dimensional flow magnetic resonance imaging visualizes drastic changes in the blood flow in a patient with Chronic thromboembolic pulmonary hypertension after pul...
- Clinical and Research Measurement Techniques of The Pulmonary Circulation: the Present and the Future.
- Il Buono, Il Brutto, Il Cattivo.
- Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of Pulmonary hypertension and right heart dysfunction associated with pulm...
- Right heart adaptation to Pulmonary arterial hypertension: physiology and pathobiology.
- Diagnosis of Pulmonary arterial hypertension.
- Towards Widespread Noninvasive Assessment of Pulmonary Vascular Resistance in Clinical Practice.
- Enhancing the accuracy of echocardiography in the diagnosis of Pulmonary arterial hypertension: looking at the heart to learn about the lungs.
- Marked changes in right ventricular contractile pattern after cardiothoracic surgery: Implications for post-surgical assessment of right ventricular function.
- Tricuspid Annular Plane Systolic Excursion in the Assessment of Right Ventricular Function in Children and Adolescents after Repair of Tetralogy of Fallot.
- A Simple Echocardiographic Method to Estimate Pulmonary Vascular Resistance.
- Estimation of oxygen consumption in elderly patients with Aortic stenosis.
- Pulmonary heart Disease: The heart-lung interaction and its impact on patient phenotypes.
- Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs.
- Simvastatin acts synergistically with ACE inhibitors or amlodipine to decrease oxygen consumption in rat Hearts.
- Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related Pulmonary hypertension.
- Assessment of Pulmonary vasculature and right heart by invasive haemodynamics and echocardiography.
- Role of nitric oxide in the control of mitochondrial function.
- Bovine polymerized hemoglobin increases cardiac oxygen consumption and alters Myocardial substrate metabolism in conscious dogs: role of nitric oxide.
- NO modulates Myocardial O2 consumption in the nonhuman primate: an additional mechanism of action of amlodipine.
- Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the Kidney.
- Relationship between plasma NOx and cardiac and vascular dysfunction after LPS injection in anesthetized dogs.
- Differentiation syndrome in non-M3 Acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
- Letter by forfia and borlaug regarding article, "Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition i...
- Diagnosis and assessment of pulmonary vascular Disease by Doppler echocardiography.
- Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated Pulmonary arterial hypertension.
- Longitudinal shortening accounts for the majority of right ventricular contraction and improves after Pulmonary vasodilator therapy in normal subjects and patients wit...
- Blood pressure response to the valsalva maneuver. A simple bedside test to determine the hemodynamic basis of Pulmonary hypertension.
- Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in Pulmonary hypertension.
- Ventilatory inefficiency reflects right ventricular dysfunction in systolic Heart failure.
- Accuracy of Doppler echocardiography in the hemodynamic assessment of Pulmonary hypertension.
- Hyponatremia predicts right heart failure and poor survival in Pulmonary arterial hypertension.
- Approach to patients with heart failure and Pulmonary hypertension.
- Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not nor...
- Tricuspid annular displacement predicts survival in Pulmonary hypertension.
- Relationship between B-type natriuretic peptides and Pulmonary capillary wedge pressure in the intensive care unit.
- Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive Heart failure.
- Endogenous nitric oxide in the control of skeletal muscle oxygen extraction during exercise.
- Reduced NO-dependent arteriolar dilation during the development of Cardiomyopathy.
- Mechanisms of nitrate accumulation in plasma during pacing-induced Heart failure in conscious dogs.
- Function and production of nitric oxide in the Coronary circulation of the conscious dog during exercise.
Schools
New York Medical College
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Philadelphia Magazine
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
New York Medical College
Drug Facts
| NPI NUMBER | 1245316058 | |
| NPPES Provider LastName | FORFIA | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 191405103 | |
| NPPES Provider State | PA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1406.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1245316058 |
| Last Name Of The Provider | FORFIA |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Ahmad B. Sarwar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Farhan Raza, MD |
|
|
Dr. Martin S. Sutton, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Scott H. Pfeffer, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William R. Sigmund II, MD |
|
|
Dr. Richard P. Shannon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yuli Y. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven G. Meister, MD |
|
|
Dr. Frank S. James, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregary D. Marhefka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel L. Dries, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bernard L. Segal, MD
This Doctor is OpenDoctor Recommended.
|